1例2型糖尿病伴骨质疏松患者的药学监护

Pharmaceutical care of a patient with type 2 diabetes and osteoporosis

目的探讨糖尿病合并骨质疏松患者的疾病特点及药学监护要点,为临床合理有效用药提供参考。方法临床药师通过参与1例2型糖尿病伴骨质疏松患者的用药分析,结合患者疾病特点及病理特征,并提出药学建议,协助治疗方案的优化。结果治疗方案重整及药学监护后,患者的治疗效果得到明显改善。结论糖尿病性骨质疏松发病机制复杂,当前的治疗以降血糖联合抗骨质疏松药物为主,通过慢病用药管理、药学监护,可以促进合理用药。

Objective To investigate the disease characteristics and key factors of pharmaceutical care in patients with diabetes and osteoporosis,and provide references for clinical rational and effective medication.Methods Clinical pharmacist participated in the drug analysis of a patient with type 2 diabetes and osteoporosis.The pharmaceutical recommendations were proposed to assist physicians in optimizing the treatment plan,combined with the patient’s disease characteristics and pathological characteristics.Results After the reorganization of the treatment plan and pharmaceutical care,the patient's treatment effect had been significantly improved.Conclusion The pathogenesis of diabetic osteoporosis is complex.The current treatment is based on hypoglycemic combined with anti-osteoporosis drugs.Through chronic disease drug management and pharmaceutical monitoring,rational drug use could be promoted.